Protalix (PLX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 10/31/19
Protalix BioTherapeutics Receives Listing Deficiency Letter from NYSE AmericanGlobeNewsWire • 08/30/19
Protalix BioTherapeutics Focuses on Evaluating and Pursuing Alternatives to Maximize Shareholder Value through Refinancing & Strategic PartnershipsGlobeNewsWire • 08/22/19
Protalix Biotherapeutics, Inc. (PLX) CEO Dror Bashan on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/08/19
Protalix Biotherapeutics, Inc. (PLX) CEO Moshe Manor on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/06/19
Protalix BioTherapeutics, Inc. (PLX) CEO Moshe Manor on Q4 2018 Results - Earnings Call TranscriptSeeking Alpha • 03/18/19